Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
GuideAI HealthNEOE:GDAI 11 EBIT per Share is C$-0.02 as of Mar. 2026. GuruFocus rates NEOE:GDAI with a GF Score™ of 11/100. Among 525 Healthcare Providers & Services companies, GuideAI Health ranks worse than 190476% on this metric.
GuideAI Health's EBIT per Share for the
three
months ended in Mar. 2026 was C$-0.01.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was C$-0.02.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for GuideAI Health's EBIT per Share or its related term are showing as below:
NEOE:GDAI's 3-Year EBIT Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 12 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
GuideAI Health's EBIT for the
three
months ended in Mar. 2026 was C$-0.70 Mil.
GuideAI Health (NEOE:GDAI) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
GuideAI Health EBIT per Share Related Terms
GuideAI Health EBIT per Share Historical Data
* Premium members only.
The historical data trend for GuideAI Health's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GuideAI Health (NEOE:GDAI) has a EBIT per Share of C$-0.02 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on GuideAI Health and its competitors. According to the industry distribution chart, GuideAI Health ranks #999999 out of 525 companies in the Healthcare Providers & Services industry.
Is GuideAI Health's EBIT per Share too high?
GuideAI Health's current EBIT per Share is C$-0.02. Based on the distribution chart, GuideAI Health ranks #999999 out of 525 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, GuideAI Health has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does GuideAI Health's EBIT per Share compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, GuideAI Health ranks #999999 out of 525 companies for EBIT per Share. This places GuideAI Health in the lower half of its industry. The industry median EBIT per Share is 12.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 12.00, based on 525 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on GuideAI Health and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 12.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. GuideAI Health's current EBIT per Share is C$-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GuideAI Health stock overvalued right now?
GuideAI Health (NEOE:GDAI) has a current EBIT per Share of C$-0.02. The current EBIT per Share is C$-0.02. GuideAI Health's overall GF Score™ is 11/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For GuideAI Health (NEOE:GDAI), the current EBIT per Share is C$-0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GuideAI Health Corp is a healthcare technology company using artificial intelligence to enable the early detection of vascular disease and support more precise treatment decisions. Its platform analyzes routine CT scans to identify peripheral vascular disease and other vascular conditions that are frequently missed or under-reported, generating structured, actionable reports for radiologists and treating clinicians. By surfacing disease earlier and matching findings to appropriate treatment pathways, it aims to improve patient outcomes while helping hospitals and radiology groups deliver more comprehensive vascular care. Its Platform Capabilities are AI-powered vascular imaging, Early detection of disease, subtle patterns and risk signals, Structured, consistent AI-generated, and Others.
11GF Score
Get the complete analysis for NEOE:GDAI
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NEOE:GDAI has been successfully added to your 
